0.67%| Prev Close: | 2.77 |
|---|---|
| Open: | 3.05 |
| Bid: | 2.96 |
| Ask: | 2.98 |
| 1y Target Est: | 7.08 |
| Beta: | N/A |
| Next Earnings Date: | N/A |
| Day's Range: | 2.92 - 3.15 |
|---|---|
| 52wk Range: | 1.61 - 4.94 |
| Volume: | 215,892 |
| Avg Vol (3m): | 92,423 |
| Market Cap: | 251.73M |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in CAD.
Headlines
- Oncolytics rises on melanoma study resultsAP(Wed 11:07AM EDT)
- ONC Makes Bullish Cross Above Critical Moving Averageat Forbes(Wed 10:48AM EDT)
- Oncolytics cancer drug meets mid-stage trial goal, shares riseat Reuters(Wed 9:44AM EDT)
- Canada Stocks to Watch: Sears Canada, Oncolytics, Canaccord and moreat The Wall Street Journal(Wed 9:18AM EDT)
- BRIEF-Oncolytics Biotech U.S.-listed shares jump 10.3 percent premarketat Reuters(Wed 8:08AM EDT)
- Oncolytics Biotech® Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma TrialCNW Group(Wed 6:30AM EDT)
- Oncolytics Biotech® Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma TrialPR Newswire(Wed 6:30AM EDT)
- Oncolytics Biotech® Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma TrialCNW Group(Wed 6:30AM EDT)
- Media Advisory - Oncolytics Biotech® Inc. to Present at Bank of America Merrill Lynch Health Care ConferenceCNW Group(Tue May 14)
- Media Advisory - Oncolytics Biotech® Inc. to Present at Bank of America Merrill Lynch Health Care ConferencePR Newswire(Tue May 14)
- Media Advisory - Oncolytics Biotech® Inc. to Present at Bank of America Merrill Lynch Health Care ConferenceCNW Group(Tue May 14)
- Oncolytics Biotech® Inc. Announces Director Election Results from its Annual and Special Meeting of ShareholdersCNW Group(Fri May 10)
- Oncolytics Biotech® Inc. Announces Director Election Results from its Annual and Special Meeting of ShareholdersPR Newswire(Fri May 10)
- Oncolytics Biotech® Inc. Announces Director Election Results from its Annual and Special Meeting of ShareholdersCNW Group(Fri May 10)
- Oncolytics Biotech® Inc. Announces First Quarter 2013 ResultsCNW Group(Thu May 9)
Press Releases
- Oncolytics Biotech® Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma TrialCNW Group(Wed 6:30AM EDT)
- Media Advisory - Oncolytics Biotech® Inc. to Present at Bank of America Merrill Lynch Health Care ConferenceCNW Group(Tue May 14)
- Oncolytics Biotech® Inc. Announces Director Election Results from its Annual and Special Meeting of ShareholdersCNW Group(Fri May 10)
Must Read
- US automakers holding off on summer factory shutdowns as demand increasesThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- TSX rallies to two-month high on Fed comments, led by minersReuters(1969-12-31T18:59:59GMT-05:00)
- US home sales rise slightly to 4.97 million in April, highest in 3 1/2 years; inventories riseThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- AAA estimates 31.2 million Americans will drive for their Memorial Day getaway this weekendThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- CP Railway reopens line, cleans up after oil spillReuters(1969-12-31T18:59:59GMT-05:00)